Viewing entries tagged
Janssen Pharmaceuticals

Risperdal Remains Top Target of Plaintiffs' Lawyer Ads

Risperdal Remains Top Target of Plaintiffs' Lawyer Ads

April marked the seventh month in a row that plaintiffs’ attorney advertisers spent over $3 million on ads seeking claims related to Risperdal, an antipsychotic drug by Janssen Pharmaceuticals, a unit of Johnson & Johnson. The drug has been among the top two drugs or medical devices targeted in mass tort ads since October 2013. Nearly 6,000 Risperdal mass tort ads ran in April. Over 85% of ad spending was devoted to ads aired on national cable and broadcast networks. The law firms of Pulaski & Middleman and Meyer Blair spent more on Risperdal ads than all other law firms combined. Read full article.